SILVIA
CALABUIG FARIÑAS
PROF. PERMANENTE LABORAL PPL
Hospital Clinic Barcelona
Barcelona, EspañaHospital Clinic Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (4)
2021
-
NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment
Molecular Oncology, Vol. 15, Núm. 9, pp. 2363-2376
2020
-
CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer
Translational Lung Cancer Research, Vol. 9, Núm. 4, pp. 1074-1083
2019
-
Prospective analysis of liquid biopsies of advanced non-small cell lung cancer patients after progression to targeted therapies using GeneReader NGS platform
Translational Cancer Research, Vol. 8, pp. S3-S15
2017
-
Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions
Annals of Oncology, Vol. 28, Núm. 9, pp. 2248-2255